OneChain Immunotherapeutics announces appointment of Dr Stefanos Theoharis as new CEO

  • Stefanos has held key positions in several renowned biotech and pharmaceutical companies and brings over twenty years of experience in the field of cell and gene therapy, business development, and program management.
  • He joins the company to lead it into its next phase of growth, forging new partnerships and focusing on areas such as manufacturing, patient recruitment and market access.
  • Under the previous leadership, the company reached the clinical phase in under than three years and reinforced its pipeline with new programs against both hematological and solid tumors.

More info